Madrigal Pharmaceuticals (STU:YDO1) FFO


STU:YDO1 Madrigal Pharmaceuticals Inc STU:YDO1
29 GF Score
Price €487.70
! 5 Warning Signs
View Full Analysis

What is Madrigal Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

STU:YDO1
29GF Score
Madrigal Pharmaceuticals Inc STU:YDO1
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Madrigal Pharmaceuticals Business Description

Other Exchanges MDGL:USA1MDGL:Italy0JXI:UK
Address 200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
29GF Score

Get the complete analysis for STU:YDO1

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€487.70
Price